Study: Higher Overall Mortality with mRNA Jabs vs. Adenovirus Vaccines

[Elderberry]

UncoverDC By Michelle Edwards -April 12, 2022

A critical Danish study published last week in The Lancet examined the possible non-specific effects (NSEs) of the novel COVID-19 vaccines. The study suggests that traditional adenovirus-based vaccines such as Johnson & Johnson and AstraZeneca may be safer for overall mortality—including COVID-19 deaths, accidental deaths and cardiovascular deaths—than the experimental mRNA-based “vaccines” manufactured by Pfizer and Moderna. The preprint, titled “Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?,” notes:

“Given the public health importance, we used the final study reports currently available from the clinical testing to examine the impact of mRNA and adenovirus-vector vaccines on overall mortality, including COVID-19-related mortality, accidents, cardiovascular deaths and other non-COVID-19 mortality.”

After reviewing the randomized clinical trials (RCTs) for the four vaccine candidates, the April 5, 2022 preprint reports that for overall mortality, with 74,193 participants and 61 deaths (mRNA:31; placebo:30), the relative risk (RR) for the Pfizer and Moderna mRNA “vaccines” compared with the placebo was 1.03. Comparatively, in the adenovirus-based vaccines there were 122,164 participants and 46 deaths (vaccine:16; controls:30). The RR for the adenovirus-based vaccines (Johnson & Johnson and AstraZeneca) versus the placebo/control vaccine was 0.37. The study notes that the adenovirus-based vaccines also demonstrated protection against COVID-19 deaths (RR=0.11), non-accident and non-COVID-19 deaths (RR=0.38). Nonetheless, as illustrated in the table below, the two types of vaccines were significantly different with respect to an impact on overall mortality.



The study explains that there now exists “ample evidence that vaccines can have broad heterologous effects on the immune system.” Furthermore, “these effects can lead to additional protection or increasing susceptibility to unrelated infections or even non-infectious immune-mediated diseases.” Expanding on this understanding further, the researchers explain that the current system for testing vaccines does not incorporate potential unexpected outcomes, adding:

“Therefore, as it has now been established in numerous studies, vaccines may have completely unexpected effects on overall mortality, different from what could be anticipated based on the protection against the vaccine-targeted disease.”



More: https://uncoverdc.com/2022/04/12/study-higher-overall-mortality-with-mrna-jabs-vs-adenovirus-vaccines/

[mountaineer]

Another otherwise healthy athlete has dropped dead from a heart attack.

Young swimmer Mariasofia Paparo dies following a heart attack
By Matthew Roscoe • 14 April 2022 • 9:55

ITALIAN swimmer Mariasofia Paparo died following a heart attack just shy of her 28th birthday and only a month after getting engaged to be married. Tributes have poured in following the news of the young woman’s death.

The swimmer died suddenly at the age of 27 after suffering a cardiac arrest in San Giorgio a Cremano (Naples) on Monday, April 11, according to local reports. ...

Euroweekly News
How many does this make now?

[mountaineer]

From an email received of Alex Berenson:

What's two times zero?
Moderna says its new Covid mRNA booster makes twice the Omicron antibodies. Think DAYS of extra protection. Yay! Also, what's with the post-booster death Moderna went out of its way not to mention?   
Alex Berenson
Apr 19   

This morning Moderna spun results from a 900-person trial testing its “variant-specific” Covid booster jab as a big positive. The usual media outlets that have failed to ask a single tough question about mRNA shots in 18 months agreed.

But reading the trial findings, as opposed to Moderna’s press release about them, offers a very different picture. The trial makes clear that tinkering with booster design does not change the core problem with the mRNA shots, which is that the antibodies the jabs produce do not last.

Worse, page 49 of the 53-page report reveals one person in the trial died after receiving a booster dose. Moderna did not discuss the death or offer any details about it anywhere else in the report - or anywhere in its its press release this morning about the trial. In fact, earlier in the report, Moderna incorrectly said that “there were no fatal events” in the trial.

Well, no fatal events except for the death that occurred after someone received a 50-microgram booster dose, leading to a “study discontinuation.” (Death makes testing for antibodies difficult.)  ...

https://alexberenson.substack.com/p/whats-two-times-zero?s=r